Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC
Kaori Sano, Kei Miyakawa, Hideaki Kato, Yayoi Kimura, Atsushi Goto, Akihide Ryo, Shinji Watanabe, Hideki Hasegawa
The paper evaluates neutralizing antibody responses against SARS-CoV-2 JN.1 variants in vaccinated individuals, finding significant immune escape by some variants but robust cross-neutralization by JN.1-based immunization.
Vaccine · Nov 5, 2024Peer-reviewedImmunology